James Simon, M.D., clinical professor of obstetrics and gynecology, was mentioned in an article in Healio's Endocrine Today on his study finding Flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, safely and effectively improved the sexual interactions of naturally postmenopausal women diagnosed with hypoactive sexual desire disorder.
Healio - Serotonin Receptor Shows Promise in Hypoactive Sexual Desire Disorder
Latest News
Firefighters from D.C. and Northern Virginia complete rigorous training to meet growing demand for advanced life-saving care.
The director of the Upward Bound program at GW has a passion for helping high school kids in D.C. achieve their higher-education dreams.
The George Washington University School of Medicine and Health Sciences Department of Dermatology received renewed support from Galderma for its efforts to redefine the understanding and management of sensitive skin throughSensitive Skin Care Research Acceleration Fund.